Latest News

  • At J.P. Morgan, Illumina CEO Outlines GRAIL’s Successful Year, Uncertain Future

    Diagnostics World News | In a somewhat subdued presentation compared to years past, Illumina CEO Francis deSouza kicked off his annual J.P. Morgan Healthcare Conference talk highlighting the breadth of the genomics market. deSouza sees a $120 billion total addressable market for Illumina, with oncology testing representing more than half of the opportunity.

    Jan 12, 2023
  • Laser-Powered Patch Monitors Hemoglobin In Deep Tissues

    Diagnostics World News | Laser diodes many times stronger than the brightness of light-emitting diodes found on the back of Apple Watches and Fitbits are enabling development of a photoacoustic skin patch capable of continuously monitoring the amount and location of hemoglobin in deep tissues. This opens the possibility of noninvasively detecting organ dysfunction, cerebral or gut hemorrhages, cancer, and COVID complications with the convenience of a wearable.

    Jan 10, 2023
  • Trendspotting: Top Diagnostics Issues in 2023

    Diagnostics World News | We spoke with various companies in the Diagnostics World community to gain insights and predictions for the coming year. They predicted faster and more precise diagnostic testing, enhanced whole genome screening, novel therapies that empower patients to direct their healthcare journey, and more advances in proteomics.

    Jan 5, 2023
  • Withings Debuts Connected Home Urine Lab

    Diagnostics World News | Since Withings founder Eric Carreel bought his company back from Nokia in 2018, the consumer electronics company has broadened its focus from nice-to-have smart health devices that support daily well-being to connected, medical-grade products whose health impacts are being scientifically validated. The latest addition to the arsenal is U-Scan, which can perform daily ​​urinalysis with a smart device that sits inside any toilet bowl.

    Jan 4, 2023
  • Global Federated Machine Learning Model Detects Glioblastoma Borders

    Diagnostics World News | In a paper published late last year in Nature Communications, researchers from Penn Medicine and Intel Labs report on what they call the largest to-date global federated learning effort to develop an accurate and generalizable machine learning model for detecting glioblastoma borders. The work has important implications both clinically and as a model for future large, federated learning projects.

    Jan 3, 2023
  • Top Stories of 2022: Post-COVID Diagnostics Market, Pan-Cancer Testing, Afib, Pregnancy

    Diagnostics World News | Diagnostics has changed in the past three years with the pandemic necessitating regulatory changes and demanding technical innovation. Some of this change has been directly COVID-related, but much was simply fueled by increased funding and attention to diagnostic problems. This year we watched the results of those changes filter through the industry and spur new thinking.

    Dec 29, 2022